Hua Jiang

Dr. Jiang has about 18 years of working experiences in the field of cancer biotherapy. She currently serves as Vice President of Early Discovery of CARsgen, responsible for formulating the strategy of early discovery and the construction of R&D pipeline. Dr. Jiang joined the Company in April 2021 as Senior Director of Immune Cell Research and Development Department, responsible for the research work of Immune Cell Research and Development and Preclinical Pharmacology. Dr. Jiang has contributed significantly to the early research, technology platform development, and innovative products development in CARsgen. Prior to joining the Company, from July 2007 to April 2021, Dr. Jiang worked at Shanghai Cancer Institute, responsible for the research and development of antibody and CAR T cells, as well as the related mechanisms. Dr. Jiang was a professor at Shanghai Cancer Institute and a doctoral supervisor at Shanghai Jiao Tong University School of Medicine.